| Name | Title | Contact Details |
|---|
Our team of accountants boasts prestigious accreditations from the Institute of Singapore Chartered Accountants and Chartered Accountants Worldwide. As a Registered Filing Agent and Qualified Individual with ACRA, we bring a wealth of expertise to the table. With experience gained from the Big 4 accounting firms, our professionals have a proven track record in serving clients across various sectors, including construction, manufacturing, and retail. We are committed to being your trusted financial advisor and tax planner, guiding you every step of the way on your journey to success. Let us help you achieve your business goals with confidence and precision.
A New Risk Management Architecture - Emerald Bay is an updated solution to solve the problems created in a fractured/dislocated market. We are structured to ensure accountability throughout the life cycle of a risk, driven by integrity of underwriting. Collaborative, Tech Enabled Underwriting - Our technical underwriting and portfolio management is supported by cutting edge technology. We work in partnership with our MGA/PA and reinsurance capital partners to ensure long term sustainability. Partnership: A Full Alignment of Interests - Our approach requires that from producer to carrier to reinsurer all partners are invested in an aligned strategy. Our laser focus is on capital protection so we are there for our insured when they most need us.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Big Brand Tire & Service is a tire and automotive service retailer founded in 1969 in Moorpark, California. With over 215 locations across six states, primarily in the Southwest US, it ranks among the top 10 largest tire dealerships in the country. The company was acquired by Percheron Capital in 2021, which has fueled its rapid expansion through multiple acquisitions. The company specializes in a wide range of tire and automotive maintenance services. It offers major tire brands such as Bridgestone, Michelin, and Goodyear, along with services including tire sales, wheel alignment, oil changes, brake inspections, and full-service auto repair. Big Brand Tire & Service emphasizes customer satisfaction and aims to be a reliable one-stop shop for tire and auto repair needs. The company is committed to maintaining its locally owned heritage while focusing on long-term growth and community support.